Latest Capital Raising News

Radiopharm Theranostics has secured FDA approval to initiate a Phase I trial targeting B7H3 and raised A$40 million to accelerate its radiopharmaceutical programs. The company also appointed renowned oncologist Dr Oliver Sartor to its Scientific Advisory Board.

Mount Burgess Mining has extinguished nearly $4.7 million in legacy debt and acquired promising gold projects in Western Australia, positioning itself for growth with a fresh capital raise and new board leadership.

Centaurus Metals has achieved a major milestone with the granting of the Jaguar Nickel Sulphide Project mining lease and reported promising new copper-gold discoveries at its Boi Novo project, underpinning its growth ambitions in Brazil.

Energy World Corporation focused on advancing its capital raising and asset sales in Q3 2025, ending the quarter with $15 million in cash but no revenue generation.

Orbital Corporation Ltd reports a robust Q1 2025 with increased revenues, successful prototype completion of a new 350cc heavy fuel engine, and strategic partnerships positioning it for growth in the evolving UAV market.

Everlast Minerals Ltd has successfully completed its IPO, raising $6 million and commencing ASX trading under ticker EV8, setting the stage for advancing its mineral sands projects in Bangladesh.

Temas Resources Corp. has successfully listed on the ASX, raising AU$11 million to advance its patented Regenerative Chloride Leach technology and strategic Québec titanium projects. The move aims to reshape Western critical metals supply chains with cost-effective, sustainable processing solutions.

Savannah Goldfields reported a challenging quarter with significant cash outflows but bolstered its position through a $15 million equity raise, setting the stage for a planned restart of gold production.

Savannah Goldfields is on the cusp of restarting gold production at its Georgetown plant, backed by promising exploration results and a $15 million capital raise to fund growth and debt repayment.

Anteris Technologies Global Corp. has had its trading suspension lifted following a key announcement about its capital raising plans, signaling renewed market activity.

Anteris Technologies Global Corp. has raised A$38.5 million in a private placement to accelerate the global commercialization and pivotal clinical trial of its innovative DurAVR® transcatheter aortic valve replacement device.

Motio Limited has raised $1.73 million through a placement to accelerate its digital display network expansion and repay debt early, aiming to reach profitability sooner.